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Abstract
Farnesol is a catabolite within the isoprenoid/cholesterol pathway that has exhibited significant antitumor activity.
Farnesol was recently identified as a quorum-sensing molecule produced by the fungal pathogen Candida
albicans. In this study, we hypothesize that synthetic and Candida-produced farnesol can induce apoptosis in vitro
in oral squamous cell carcinoma (OSCC) lines. Cell proliferation, apoptosis, mitochondrial degradation, and survivin
and caspase expressions were examined. In addition, global protein expression profiles were analyzed using pro-
teomic analysis. Results demonstrated significant decrease in proliferation and increase in apoptosis in cells ex-
posed to farnesol and C. albicans culture media. Concurrently, protein expression analysis demonstrated a
significant decrease in survivin and an increase in cleaved-caspase expression, whereas fluorescent microscopy
revealed the presence of active caspases with mitochondrial degradation in exposed cells. A total of 36 dif-
ferentially expressed proteins were identified by proteomic analysis. Among the 26 up-regulated proteins were
those involved in the inhibition of carcinogenesis, proliferation suppression, and aging. Most notable among
the 10 down-regulated proteins were those involved in the inhibition of apoptosis and proteins overexpressed
in epithelial carcinomas. This study demonstrates that farnesol significantly inhibits the proliferation of OSCCs
and promotes apoptosis in vitro through both the intrinsic and extrinsic apoptotic signaling pathways. In addition,
we report for the first time the ability of Candida-produced farnesol to induce a similar apoptotic response through
the same pathways. The capability of farnesol to trigger apoptosis in cancer cells makes it a potential tool for
studying tumor progression and an attractive candidate as a therapeutic agent.
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Introduction
Apoptosis, or programmed cell death, is a gene-controlled, tightly
regulated process, which occurs naturally during embryogenesis
and in development and is used to control the proliferation of unde-
sired or genetically altered mammalian cells without the induction of
an inflammatory response [1,2]. The inhibition or deregulation of
this process, combined with altered cell proliferation, provides the
basis for many cancerous diseases such as oral squamous cell carci-
noma (OSCC), accounting for more than 90% of head and neck
cancers, with an estimated 35,310 new cases and 7590 deaths ex-
pected in 2008 in the United States alone [3].
In mammalian cells, apoptotic cell death can be triggered by many
different extracellular and intracellular stimuli resulting in the activa-
tion of extrinsic and intrinsic apoptotic signaling pathways involving
both the death domain pathways and the mitochondria, as well as
various downstream caspases [4,5]. Mitochondrial degradation and
fragmentation of the nuclear genome are major cellular responses
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characteristic of apoptosis conducted by multiple nucleases activated
by apoptotic signaling pathways [4,5].
Caspases are a class of cysteine–aspartic acid proteases regulated at
the posttranslational level, which, when cleaved, convey an apoptotic
signal in a proteolytic cascade that induces apoptosis and leads to cell
death [4,5]. Caspase 3, in particular, is the major effector caspase in
apoptotic cells, which, on activation, is cleaved into a large subunit
and a smaller subunit resulting in a pivotal event in the execution of
apoptosis [4,5].
Survivin, a member of the inhibitor of apoptosis family of pro-
teins, is shown to be associated with carcinogenesis including oral,
tonsillar, esophageal, and laryngeal OSCC, and its expression is cor-
related with an adverse prognosis and poor survival rates [2,6,7]. In
addition, survivin has been implicated in the regulation of both the
extrinsic and intrinsic apoptotic signaling pathways, interacting di-
rectly and indirectly with caspase 3 and 9 [4].
Among the recently identified extracellular stimuli of apoptosis in
human tumor cells is farnesol, a naturally available sesquiterpene
alcohol and a key intermediate in de novo synthesis of cholesterol
in all mammalian cells [8–11]. Interestingly, although farnesol was
shown to induce apoptosis in different types of human cancer cells,
it seems to preferentially induce apoptosis in neoplastic cells versus
nonmalignant cell [8–12].
Studies on the apoptotic effects of farnesol on certain human
tumor cells demonstrated that the addition of farnesol resulted in
the rapid inhibition of phosphatidylcholine (PC) synthesis due to
the inhibition at the cholinephosphotransferase step [1]. Phosphati-
dylcholine is the most abundant lipid present in eukaryotic cell
membranes comprising ∼50% of cellular phospholipid mass. Diacyl-
glycerol (DAG), a protein kinase C activator, is a lipid second mes-
senger that acts as a signaling molecule and regulates cell growth and
apoptosis [1]. In those studies, the exogenous administration of DAG
significantly reduced farnesol-induced apoptosis but did not rescue
PC synthesis [1]. It was concluded from these observations that
farnesol-induced apoptosis is likely due to farnesol’s activation of a
DAG-mediated process that results in the induction of apoptosis
or inhibition of a DAG-dependent process that is required for cell
proliferation [11].
In addition to its identification as an inducer of apoptosis in
mammalian tumor cells, farnesol was recently identified as a quorum-
sensing molecule produced and extracellularly secreted by the most
important human fungal pathogen Candida albicans [13,14]. In
C. albicans, farnesol is endogenously generated in the cell by enzymatic
dephosphorylation of farnesyl diphosphate, a precursor for the synthe-
sis of sterols in the sterol biosynthesis pathway [12,15].
Candida albicans is a dimorphic species capable of changing its
morphology from the yeast form to the hyphal form, a transition
critical to its pathogenesis, which is triggered by quorum-sensing
molecules [13,14]. In addition to its involvement in morphogenesis,
quorum sensing is a strategy of cell-cell communication benefiting
a microbial community by controlling unnecessary overpopulation
with important implications for the infectious process.
The involvement of quorum sensing in C. albicans morphogenesis
was demonstrated by us and others through the recent identification
of farnesol, where both exogenous and Candida-produced farnesol
was shown to suppress hyphal formation [13,14]. Our studies, how-
ever, also demonstrated that farnesol is increasingly produced by
Candida in culture in a manner proportional to cell density and
age of culture; and at certain concentrations, is capable of killing
the fungal cell [15]. Therefore, although the phenomenon of apopto-
sis in C. albicans has not been previously investigated, it is conceiv-
able that C. albicans may use farnesol as a strategy for programmed
cell death to control cell proliferation. The hypothesis of this current
study was to determine the existence of a Candida-induced apoptotic
mechanism on human OSCCs by way of farnesol. Specifically, using
primary OSCC lines as a model, this study was designed to charac-
terize a farnesol-induced apoptotic axis and to determine whether the
C. albicans–secreted quorum-sensing molecule, identified as farnesol,
triggers apoptosis. Further, we sought to identify potential pathways
and proteins involved in this process.
Advances in proteomic technology offer great promise in the un-
derstanding and treatment of the molecular basis of disease. Specifi-
cally, the study of dynamic protein expression has culminated in the
identification of many disease-related biomarkers and potential new
drug targets. Therefore, in addition to the assessment of classic apop-
totic markers in human tumor cells, a global proteomic approach
was used to elucidate the mechanisms underlying the antitumor
activity of farnesol and to unravel altered protein expression after
farnesol treatment.
Materials and Methods
Cell Lines and Cell Cultures
All experiments were performed using two established primary
human tongue squamous cell carcinoma cell lines (OSCC 9 and
OSCC 25) from the American Type Culture Collection (ATCC,
Manassas, VA). Cells were cultured in 1:1 mix of Ham’s F12 and
Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum,
100 U of penicillin, 100 μg/ml streptomycin, and 0.4 g/ml hydro-
cortisone (Sigma Chemical Co., St. Louis, MO). The cells were cul-
tured at 37°C in a 5% CO2 air atmosphere until confluent and
subcultured using a disaggregration assay with Trypsin (0.1%) and
EDTA (0.01%) in phosphate-buffered saline (PBS) pH 7.5. For all
experiments, cells were grown in 6- or 24-well plates at 5 × 104 cells
per well and grown to 80% confluence. Control cells for all ex-
periments were treated with the vehicle alone (0.1% methanol) in
normal medium (NM). All experiments were performed on three
separate occasions.
Candida albicans SC5314 and a non–farnesol-producing strain
C. albicans (ATCC 10231) [16] were maintained on Sabouraud dex-
trose agar (BBL, Cockeysville, MD) and cultured in YNB [0.67%
yeast nitrogen base (pH 7.0), 50 mM glucose]. Cultures were grown
overnight in an orbital shaker at 30°C under aerobic conditions. Cells
were harvested and washed twice in sterile PBS. To obtain C. albicans
spent culture medium (CA), C. albicans biofilms were formed on
the surfaces of 75-cm2 tissue culture flasks in RPMI-1640 supple-
mented with L-glutamine and buffered with HEPES (Invitrogen,
Grand Island, NY) to a cell density of 1 × 106 cells/ml and grown
for 48 and 72 hours. Culture supernatants were then collected, filter-
sterilized, and diluted 1:1 with fresh RPMI-1640 [13]. In all experi-
ments, fresh media were included as negative controls.
Farnesol Treatment of OSCCs
Farnesol (Sigma) was obtained as a 3-M stock solution and diluted
to a 30-mM solution in 0.1% methanol. Previous experiments had
shown that methanol did not affect cell viability at the concentration
used in these experiments [13]. Cells grown were then either left
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untreated or treated with synthetic farnesol at 30- and 60-μM final
concentrations. Similarly, cells were also grown in the sterilized
C. albicans spent CA from both the farnesol-producing and non–
farnesol-producing strains of C. albicans. Simultaneously, experi-
ments were performed as described above with a DAG analog
(1,2-dioctanyl-sn-glycerol; Sigma) added, and plates were incubated
for 48 hours.
Cell Proliferation
For cell proliferation assays, cells were treated with increasing con-
centrations (10, 30, 50, and 60 μM) of synthetic farnesol to deter-
mine IC50. For all other experiments, cells were treated with 30 or
60 μM farnesol or with conditioned media from farnesol- or non–
farnesol-producing C. albicans as described above for 48 hours. The
cells were removed enzymatically and counted using a Coulter
Counter (Model ZI; Coulter, Miami, FL). The percent of cell growth
was determined by setting as 100% the growth of cells treated with
the vehicle alone (NM; 0.1% methanol) and calculating all others to
this level. All analyses were performed in triplicate.
Flow Cytometry (Apoptosis Analysis)
Following the same treatments as described above, apoptosis was
evaluated using Annexin V–FITC methods. Cells were washed with
PBS, followed by lysis using Trypsin (0.1%) and EDTA (0.01%) in
PBS at pH 7.5. The cells were washed with normal medium and
cold PBS and resuspended in 1× binding buffer (BD-Pharmingen
Biosciences, San Diego, CA). Five microliters of Annexin and 5 μl
propidium iodide were added to cells, vortexed, and incubated for
15 minutes in the dark. Finally, 400 μl of 1× binding buffer was
added, and samples were evaluated by flow cytometry. The percent
of apoptosis was determined by setting as 0% the apoptosis of cells
treated with the vehicle alone (NM; 0.1% methanol) and calculating
all others to this level. All analyses were performed in triplicate.
Western Blot
Following the same treatments as described above, cells were
incubated and washed twice with ice-cold PBS, followed by lysis
using radioimmunoprecipitation assay buffer [50 μM Tris (pH 7.4),
150 μM NaCl, 1% Triton X-100, 1% deoxycholic acid, 150 μM
sodium salt, 0.1% SDS, 100 μg/ml phenylmethysulfonyl flouride,
1 μg/ml aprotinin, 1 mM dithiothreitol (DTT), 1 mM sodium ortho-
vanadate] for 10 minutes at 4°C. The wells were then scraped, and
cells were recovered and centrifuged at 40,000g for 15 minutes at
4°C. The recovered proteins were measured and equalized using the
Bio-Rad Protein Assay (Bio-Rad Laboratories, Richmond, CA) per
manufacturer’s instructions and were electrophoresed on a 15% acryl-
amide gel. Western blot analysis was performed using a 1:1000 dilu-
tion of monoclonal primary antibodies for survivin (Abcam, Cambridge,
UK), cleaved-caspase 3 (Cell Signaling, Beverly, MA), and cleaved-
caspase 9 (Cell Signaling), with β-actin (Sigma) used as a loading con-
trol. Blots were processed with lumiGLO (KPL, Upstate, Waltham,
MA) exposed for radiographic imaging, then stripped, and reprobed
with β-actin antibody. All analyses were performed in triplicate.
Confocal Laser Microscopy
Active caspases were detected microscopically using FLICA
Apoptosis Detection Kits (Immunochemistry Technologies, LLC,
Bloomington, MN) according to manufacturer’s recommendation.
Apoptotic cells fluoresce green, whereas nonapoptotic cells appear
unstained. Similarly, mitochondrial degradation was evaluated using
Mitochondrial Permeability Transition Detection Kit MitoPT 924
(Immunochemistry Technologies) according to the manufacturer’s
recommendation. Apoptotic cells treated with MitoPT reagent ap-
pear green; nonapoptotic cells appear red. Processed samples were
observed with a confocal microscope (with video capture system,
automatic camera, and image analysis hardware software; Axiovert
100; Zeiss, Berlin, Germany) using 20×, 40×, and 100× oil immer-
sion objectives. Confocal images of green and red fluorescence were
collected simultaneously using the Z-stack mode. Imaging of stained
cells were accomplished by using a protocol with an excitation wave-
length of 488 nm and emission peaks at 528 and 617 nm for green and
red, respectively. Images were processed for display by using Axiovision
3.x software (Zeiss).
Reversal of Apoptosis by Exogenous DAG
Cell proliferation and caspase protein expression assays were also
performed in the presence of DAG. Cells were grown with synthetic
farnesol (0, 30, or 60 μM) and in C. albicans spent culture media as
previously described in the presence and absence of 30 μg/ml DAG
analog for 24 hours.
Proteomic Analysis
Two-dimensional gel electrophoresis and matrix-assisted laser de-
sorption ionization–time of flight mass spectrometry (MALDI–ToF
MS) were used to compare the proteomes of treated versus untreated
OSCCs as described in previous studies [17–20].
Reagents
Urea, thiourea, trichloroacetic acid, iodoacetamide, and phenyl-
methysulfonyl flouride were obtained from Sigma-Aldrich Chemical
Inc. (St. Louis, MO); the Immobiline Dry Strips (pH 3-10 nonlinear),
Pharmalytes (3-10), DTT, 3[(3-Cholamidopropyl)dimethylammonio]-
propanesulfonic acid, the Multiphor II isoelectric focuser, and Höefer
DALT Vertical System were obtained from Amersham Biosciences
(Piscataway, NJ).
Two-dimensional Gel Electrophoresis
Two-dimensional gel electrophoresis was conducted as outlined by
Gorg et al. [21]. Cytosolic proteins were extracted from cell lines
as previously described. To accomplish rehydration of the protein,
500 μg of crude protein was extracted by adding a 1/10 volume of
an ice-cold 1:10 mixture of trichloroacetic acid and acetone (Sigma).
The resulting pellet was then directly solubilized in rehydration
buffer (0.1 mM urea, 25 μM thiourea, 0.35 μM DTT, 0.5% w/v
CHAPS, and 1.6% Pharmalyte 3-10). These samples were applied
to 18-cm, pH 3-10, NL Immobiline Dry-Strips (GE Healthcare,
Piscataway, NJ). Isoelectric focusing, which separated the pro-
teins based on their pI , was performed using a Multiphor II from
Amersham (Amersham Biosciences) as per manufacturer’s directions.
Before the second dimension, the immobilized pH gradient strips
were equilibrated (as per manufacturer’s directions) and subsequently
applied to SDS-PAGE gels. For the resolution of crude protein ex-
tracts in the second dimension, a 26 × 20-cm2 two-dimensional gel
system from Höefer DALT Vertical System (Amersham Biosciences)
was used. Crude protein extracts were separated at 10°C on an 11%
resolving gel, which was then nondestructively silver-stained. As previ-
ously mentioned, each treatment was performed in three independent
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replicates. In addition, duplicate runs were performed on each repli-
cate to ensure the accuracy of analyses. Stained gels were scanned
(300-dpi resolution), and gel images were analyzed with PDQuest
version 7.0 (Bio-Rad Laboratories). Differentially expressed proteins
were selected for identification. Spots of interest were excised and sub-
jected to trypsinization.
MALDI–ToF MS Analysis
Only those spots which changed consistently and significantly
(>1.5-fold) were selected for analysis by mass spectrometry (MS).
Spots of interest were excised and subjected to trypsinization. Pep-
tides were extracted and analyzed using MALDI–ToF MS. An Ap-
plied Biosystems Voyager-DE STR MALDI–ToF MS was used,
functioning in a positive-ion mode with α-cyano-4-hydroxycinnamic
acid matrix for ionization. At least 100 laser shots per spectrum were
averaged. Mass spectral peaks with a signal-to-noise ratio greater than
5:1 were deisotoped, and the resulting monoisotopic masses were
used for protein identification using mass fingerprint analysis. The
software used for protein identification was the Profound search engine
using the Genomic Solution’s Knexus software (ver 2004.03.15), and
the database used was the latest NCBI nonredundant database ob-
tained from the National Institutes of Health.
Statistical Analysis
For all measurements as needed, a Student’s t test was used to as-
sess the statistical significance of treated groups versus control groups
along with SE. A statistically significant difference was considered to
be present at P < .05. Protein spots were considered to represent dif-
ferentially expressed proteins if they were up- or down-regulated
≥1.5-fold in three independent experiments for two-dimensional
gel electrophoresis experiments. The protein spots that were identi-
fied as differentially expressed were positively identified by MALDI–
ToF MS and database comparison if they received an expectation
score of 1 × 10−3 or less.
Results
Results from all experiments performed were consistent for both
cell lines, and therefore, only data from one of the cell lines used
(OSCC 9) are presented.
Farnesol-Induced Cell Growth Inhibition and Apoptosis
Determination of cell proliferation. Cell proliferation data in-
dicated that exposure to 30 to 60 μM synthetic farnesol (F30 or
F60) for 48 hours resulted in a significant 56.25% and 53.7% de-
crease in proliferation of OSCCs compared to vehicle only–treated
cells (NM), respectively (P < .05; Figure 1A). Similarly, exposure to
C. albicans spent culture media grown for 48 or 72 hours (CA48h
or CA72h) and treated for 48 hours on OSCCs decreased cell pro-
liferation significantly by 30% to 35% (P < .05; Figure 1B). Inter-
estingly, no significant differences in proliferation were observed
between the different C. albicans growth culture incubation periods
(CA48h or CA72h) or between farnesol 30- and 60-μM treatments
(P < .05). Further, exposure to spent culture media of the C. albicans
non–farnesol-producing strain cultured at 48 or 72 hours (NF48h
or NF72h) and treated for 48 hours on OSCCs did not affect cell
proliferation (Figure 1B).
Reversal of apoptosis by exogenous DAG. Proliferation assays were
also performed in the presence of DAG to determine whether DAG
was able to salvage OSCCs from apoptosis induced by farnesol.
These studies indicated that the addition of DAG (DAG-F30 or
DAG-F60) was able to maintain cell proliferation at 100% in the
presence of 30- to 60-μM farnesol treated for 48 hours (Figure 1B).
Flow cytometry (apoptosis analysis). The effect of farnesol on cell
proliferation was corroborated by the data obtained from Annexin V
apoptosis studies after treatment of OSCCs for 48 hours with 30-
to 60-μM farnesol or 48- to 72-hour-old C. albicans spent culture
media. In these studies, cells exposed to synthetic and C. albicans
farnesol exhibited 7.3% to 10.06% apoptosis compared to unexposed
cells (P < .05; Figure 2).
Western blot analysis. Proteins were extracted from OSCCs after
48 hours of exposure to 30- to 60-μM synthetic farnesol (F30 or
F60) or C. albicans spent culture media grown from 24 to 72 hours
from farnesol-producing (CA48h or CA-72h) and non–farnesol-
producing (NF24h, NF48h, or NF72h) C. albicans strains and
Figure 1. Cell proliferation assay: Assessment of OSCC 9 cell pro-
liferation, all after 48 hours of treatment compared to control-
vehicle–treated cells (NM). Decrease in tumor cell proliferation
after exposure to (A) synthetic 30- to 60-μM farnesol (F30, F60;
>57%) or (B) C. albicans spent culture media grown for 48 to
72 hours (CA48h, CA72h; >35%) without a change in proliferation
with the non–farnesol-producing C. albicans spent culture media
grown for 48 to 72 hours (NF48h, NF72h). Additionally, a reversal
of the proliferation inhibition is seen by the addition of DAG com-
bined with F30 and F60 (DAG-F30, DAG-F60), with DAG by itself
(DAG) inducing no effect. The growth of control-vehicle–treated
cells (NM) has been set to 100%, to which all other measures
were calculated. Error bars, SEM. *Statistically significant (P <
.05) differences compared to control cells, non–farnesol-producing
C. albicans and to the addition of DAG, respectively.
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treated for 48 hours on OSCCs. After SDS-PAGE and Western
blot analysis, membranes were probed with antibodies to survivin,
cleaved-caspase 3, and cleaved-caspase 9. These studies demonstrated
a significant decrease in survivin expression in the synthetic and
Candida-produced farnesol-exposed OSCCs but no change in
survivin expression with the non–farnesol-producing C. albicans
strain (Figure 3A). Analysis of cleaved-caspases 3 and 9, however,
demonstrated an increase in caspase expression in the farnesol and
C. albicans spent culture media–exposed cells. Similar to the prolif-
eration studies, however, caspase expression was restored to baseline
levels in the presence of DAG treatment for 48 hours (Figure 3B).
Fluorescent microscopy. To confirm the active caspase protein ex-
pression findings and the presence of apoptosis, fluorescent micro-
scopic assays were performed using apoptosis and mitochondrial
degradation FLICA Apoptosis Detection Kits that detect the pres-
ence of intracellular active caspases and mitochondrial damage.
Microscopic images revealed the presence of green fluorescence in
the synthetic farnesol–exposed cells indicating the presence of active
caspases (Figure 4B). Similarly, intracellular red fluorescence indica-
tive of mitochondrial degradation was seen in these farnesol-exposed
cells (Figure 4; similar images were obtained with 30 μM farnesol).
Proteomic analysis. Three independent proteomic analyses showed
high reproducibility in demonstrating a significant number of proteins
to be differentially regulated on 48 hours of treatment with either syn-
thetic (F30 or 60) or C. albicans spent culture medium farnesol
(CA48h or CA72h; Figure 5). Of these 36 proteins, 26 were consis-
tently up-regulated and 10 were down-regulated in the three indepen-
dent cell culture experiments. The 36 differentially expressed spots
were subjected to MALDI–ToF MS analysis and database searching,
which resulted in the identification of most these proteins (25/36).
The proteins identified and the detailed peptide data are provided in
Table 1.
Most notable among the down-regulated proteins involved in
OSCC are as follows: glutathione S -transferase, a protein involved
in hypermethylation; heat shock protein 27 kDa (HSP27), an inhib-
itor of apoptosis; RAN, a contributor to genetic instability and cell
cycle progression; and various keratins overexpressed in epithelial car-
cinomas and dysplastic lesions (Table 1A).
Among the significantly up-regulated are various proteins involved
in the inhibition of carcinogenesis (Table 1, B and C ). Most notable
are proteins involved in tumor immune function (Met enkephalin),
proliferation suppression (Mdm-2, laminin-binding, Annexin A2,
transketolase), and the aging-associated protein YWHAZ.
Discussion
Apoptosis is a naturally occurring developmental process triggered
by various extracellular and intracellular stimuli and is divided clas-
sically into extrinsic and intrinsic pathways [7]. The extrinsic path-
way typically involves the activation of death domain receptors and
Figure 2. Annexin V apoptosis assay: Assessment of OSCC 9 cell
apoptosis, all after 48 hours of treatment compared to control-
vehicle–treated cells (NM). Results demonstrated an increase in
apoptosis with synthetic 30- to 60-μM farnesol-treated cells (F30,
F60) or C. albicans spent culture media grown for 48 to 72 hours
(CA48h, CA72h). The apoptosis of control-vehicle–treated cells
(NM) has been set to 0%, to which all other measures were calcu-
lated. Error bars, SEM. *Statistically significant (P < .05) differ-
ences compared to control (NM) cells.
Figure 3. Western blot analysis: Assessment of OSCC 9 cell protein expression, all after 48 hours of treatment, demonstrating (A)
a decrease in survivin expression and (B) an increase in cleaved-caspase 3 and cleaved-caspase 9 expression in cells exposed to syn-
thetic 30- to 60-μM farnesol (F30, F60) or C. albicans spent culture media grown for 48 to 72 hours (CA48h, CA72h), without a change
in expression with the non–farnesol-producing C. albicans spent culture media grown for 24 to 72 hours (NF24, NF48h, NF72h). The
restoration of caspase expression to baseline levels is seen in the presence of 48 hours of combined DAG and farnesol (DAG-F60)
treatment. Actin was used as the loading control.
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the downstream regulation and activation of caspase 3 [4,5]. The
intrinsic pathway elicits the degradation of the mitochondria and ac-
tivation of the intermediary caspase 9, which, when cleaved, induces
caspase 3 activation, a terminal caspase for both pathways [4,5].
Among the recently identified extracellular stimuli of apoptosis
in mammalian tumor cells is farnesol, an extracellularly secreted
quorum-sensing molecule by the fungal species C. albicans [1]. In
this investigation, studies were designed to examine and compare
the apoptotic effects of both synthetic farnesol and C. albicans–
produced farnesol secreted into culture medium on OSCCs. To that
end, two primary OSCC lines were used as a model, and analyses
of apoptotic markers and two-dimensional–based proteomics were
undertaken to annotate the altered proteins in the cells before and
after exposure to farnesol.
To date, the exact mechanism of farnesol cytotoxicity is yet to be
elucidated. However, it has been suggested from limited studies that
farnesol’s effect may be due to interference with a phosphatidylinositol-
type signaling secondary to decreased levels of intracellular DAG.
The result inducing the triggering of caspases and inhibition of
survivin, leading to cell disassembly and growth inhibition [2]. Al-
though the exogenous administration of DAG in those studies pre-
vented farnesol-induced inhibition of cell proliferation, it did not
relieve the farnesol-induced block in PC synthesis [2]. Thus, the
execution of apoptosis by farnesol seems to be a separate and dis-
tinct event from farnesol-induced inhibition of PC biosynthesis and
instead likely occurs through a DAG-mediated process that is down-
stream of PC synthesis [2]. These observations were corroborated
by our study, where the addition of DAG reversed the inhibitory effect
of farnesol on cell proliferation and on caspase expression (Figures 1
and 3).
Farnesol has been reported to induce cell growth inhibition and/
or apoptosis in a variety of tumor cells; however, the reported IC50
values varied widely for different tumor types and different cell lines
[22]. In our study, we observed an IC50 value of 30 to 60 μM for
farnesol on the OSCC lines in our study.
Our cell proliferation studies indicated that the exposure to syn-
thetic or Candida-produced farnesol resulted in a significant decrease
in the proliferation of OSCCs compared to unexposed cells. To vali-
date our findings, a non–farnesol-producing Candida strain was in-
cluded. In these experiments, exposure of OSCCs to C. albicans
spent culture medium from this strain had no effect on cell prolifera-
tion or apoptosis (Figures 1 and 3).
To elucidate the pathways involved in farnesol-mediated apoptosis,
Western blot and fluorescent microscopic analyses were performed.
Fluorescent images demonstrated the intracellular presence of mito-
chondrial degradation and activated caspases in the farnesol-exposed
cells. In addition, the overexpression of terminal cleaved-caspases and
the presence of cleaved activated subunits were also demonstrated in
the farnesol-exposed cells, along with a decrease in the expression
of the intermediary apoptosis–inhibiting protein survivin (Figure 3).
These findings indicate that both the intrinsic and extrinsic apoptotic
signaling pathways are activated using farnesol.
The involvement of both apoptotic pathways was further dem-
onstrated through proteomic analysis. The induction of death do-
main receptors at the cell surface induces the activation of caspase
8, which cleaves and activates caspase 3 inducing apoptosis [23].
However, HSP27, a protein associated with a wide range of human
cancers and associated with a poor prognosis and resistance to ther-
apy, has been shown to prevent apoptosis by suppressing the acti-
vation of procaspase 9 [24]. Interestingly, HSP27 was found to be
underexpressed after farnesol treatment, as shown by our proteomic
analysis supporting the hypothesis that farnesol in vitro triggers
apoptosis in OSCCs through both intrinsic and extrinsic apoptotic
signaling pathways.
Through global proteomic analyses of farnesol-exposed and non–
farnesol-exposed cells, a total of 58 altered proteins were visual-
ized by two-dimensional gel electrophoresis and Coomassie brilliant
blue staining. Of those, 36 proteins were excised and analyzed by
MALDI–ToF MS, where 25 proteins were positively identified, in-
cluding those which function in diverse biologic processes, such as
Figure 4. Fluorescent microscopic images revealing the presence of (A) active caspases and (B) mitochondrial degradation in the 60-μM
farnesol-treated cells (F60) compared to control (F0). Active caspases are seen as green fluorescence, whereas mitochondrial degrada-
tion appears as red fluorescence. Minimal fluorescence was observed in the untreated-control cells (0F). Bar, 20 μm.
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Figure 5. Representative two-dimensional gels of extracted proteins from OSCC 9 cells, all after 48 hours of treatment and grown in the
presence of 30- to 60-μM farnesol (F30, F60) or C. albicans spent culture media grown for 48 hours (CA48h) demonstrating differential
protein expression. Thirty-six protein spots (marked with arrows and numbers) displayed consistent alterations on farnesol treatment.
Information on the identities and functions of these spots is listed in Table 1.
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protein binding and folding, metabolism, proteolysis, signal trans-
duction, carcinogenesis, aging, and programmed cell death (see
Table 1) [25–55]. Among the 36 proteins found with differential
regulation, 10 were down-regulated (Table 1A) and 26 were up-
regulated by farnesol treatment (Table 1, B and C ). Most notable
among the down-regulated proteins, cofilin 1 is assumed to play a
role in leukemias and metastasis [40]. The down-regulation of these
proteins may play a role in farnesol-mediated growth inhibition of
OSCCs and in the induction of apoptosis.
Among the 26 proteins displaying significant overexpression, 15
proteins were identified (Table 1, B and C ). Among those, three were
found to be up-regulated with only 60-μM farnesol (Table 1C ). Al-
though not quite clear, this could possibly be related to a greater
threshold needed to overcome counteracting inhibitory factors,
native to the cancer cells. In addition to proteins involved in pro-
grammed cell death (an aging-associated gene 9 protein), both An-
nexin A2 (ANXA2), a calcium-binding protein, and Annexin V, a
calcium-dependent phospholipid-binding protein, members of the
ANX family, were among the up-regulated proteins [35,42,45,47].
Both of these proteins have been shown to be up-regulated in human
tumors and play a role in cell growth and cell signaling [35,42].
ANXA2 is a multifunctional Ca2+, lipid, and actin-binding protein,
which is implicated in a number of intracellular functions such as cell
signaling, membrane trafficking, mRNA transport, and regulation of
membrane/cytoskeleton contacts and extracellular functions [42].
The precise biologic function of Annexin V, although a widely dis-
tributed protein, is yet to be established. However, it is reported to be
an intracellular inhibitor of protein kinase C (PKC) [35]. Interest-
ingly, the activation of conventional PKC groups are dependent on
the presence of Ca+, phosphatidylserine (PS), and DAG that are in-
hibited by Annexin V and, in turn, counteract the phosphorylation
by PKC by Annexin I, Annexin II, and histone IIIS [56].
A comparison between the protein expression in cells grown in syn-
thetic farnesol and those grown in 48- and 72-hour-old C. albicans
Table 1. Proteins Differentially Regulated with Farnesol.




(A) Proteins down-regulated with farnesol
[34] 1 17,028.9 8.54 Cofilin-1 p18 isoform 4 96.3 73983054 Expressed in leukemias, role in metastasis
[30] 2 23,595.1 5.43 Glutathione S -transferase 4 99.5 2204207 Associated with carcinogenesis through hypermethylation
[27] 3 22,825.5 5.98 Heat shock protein 27 kDa 9 100 4504517 Expressed in squamous cell carcinomas and leukemias,
associated with poor prognosis, up-regulated with
chemotherapy to inhibit apoptosis
[25] 4 25,378 7.16 RAN protein 5 99.9 32425497 Contributes to genetic instability characterizing many
cancer cells, transformation and cell cycle progression
[28] 5 60,323.4 7.59 Keratin 5A 15 100 46812692 Overexpressed in epithelial carcinomas, progression,
and metastasis
[28] 5 60,323.4 7.59 Keratin 6A 16 100 46812692 Overexpressed in epithelial carcinomas
[28] 7 51,874.5 5.09 Keratin 14 14 100 15431310 Overexpressed in epithelial carcinomas, metastasis
[28] 8 48,361.1 4.97 Keratin 17 7 100 4557701 Early expression in all dysplastic lesions, metastasis
[33] 9 47,797.1 5.61 ARP3 actin-related protein 3 homolog 6 100 27882036 Involved in actin polymerization and cell motility
(B) Proteins up-regulated with farnesol
[31] 11 18,554 4.93 Met Enkephalin 3 95.2 223431 Suppresses immune function
[29] 13 25,249.8 4.87 Mdm2-B 4 100 992679 Growth-inhibitory functions, overexpressed with
mutant p53
[26] 14 30,099.9 4.72 YWHAZ 4 99.9 49119653 Role in human aging, metastasis, poor prognosis
in cancer
[48] 15 23,235.7 5.02 Rho GDP dissociation inhibitor 9 100 36038 Overexpressed in cancer, resistance to treatment
[39] 16 26,509.4 4.95 Chloride intracellular channel-1 9 100 55961619 Overexpressed in cancer
[35] 17 35,840.4 4.94 Annexin V (Chain-C) 6 100 809190 Overexpressed in cancer, marker of apoptosis
[38] 18 31,888 4.84 Laminin-binding protein 5 95.1 34234 Overexpressed in cancer, role in cell adhesion,
mitogenesis, differentiation, and metastasis
[36] 19 29,431.7 4.86 Similar to 40S ribosomal protein SA 5 96.5 109041487 Lamin receptor, multidrug resistance
[42] 21 38,807.9 7.57 Annexin A2 6 100 50845386 Overexpressed in cancer, proliferation, differentiation,
and metastasis
[51] 23 36,197.5 8.57 Aging-associated gene 9 protein 6 100 54303910 Involved in programmed cell death
[43] 26 29,002.9 6.67 Phosphoglycerate mutase 1 5 100 89035672 Inhibitor of enzyme in glycolytic pathway,
cell immortalization
[37] 28 68,519 7.58 Transketolase 11 100 14602962 Nucleic acid ribose synthesis → proliferation
and survival
(C) Proteins up-regulated with 60 μM farnesol
[50] 34 24,536.5 4.85 Alpha-S1-casein 6 100 162794 Activation of protein kinase p40TAK a casein kinase 2
in epithelial cancer
[53] 35 27,386.9 4.71 Tropomyosin 3 18 100 47938162 Cytoskeletal microfilaments, implicated in cancer as
a possible oncogene
[28] 36 66,198.1 8.16 Keratin 1 13 100 17318569 Squamous cell differentiation, overexpressed in
epithelial cancer
*Peptide count for peptide in the spectra of tryptic digests that matched the proteins identified.
†Proteins identified by mass spectrometry are assigned a MOWSE scoring algorithm expressed as a protein score for a peptide mass fingerprint. Protein scores higher than 65 indicate with 95%
confidence [protein score confidence interval (CI)] that the proteins were not identified by random matches of peptide mass data. The closer the protein score of % CI value is to 100%, the more
likely the protein is correctly identified.
‡Large reviewed computational analysis by The FANTOM Consortium and RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group).
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spent culture media demonstrated a similar pattern of differentially ex-
pressed proteins indicating the presence of a substance in the media
exerting similar effect on OSCCs to those observed with synthetic
farnesol. Although the pattern of expression was similar between
growth in 48- and 72-hour-old C. albicans spent culture media,
the level of expression was more pronounced in cells grown in the
48-hour-old C. albicans spent culture media, which more closely re-
sembled the intensity of protein expression pattern of the cells grown
in 30-μM synthetic farnesol. Farnesol has been shown to be increas-
ingly produced with the age of the culture at a reported estimated con-
centration of 35 μM in 24- to 48-hour-old cultures, consistent with
the comparable effects of the C. albicans spent culture media to that of
30-μM farnesol on the OSCCs observed in our study [15].
Although the clinical implications of the Candida-induced apop-
totic effect on OSCCs are not yet clear, the incidence of OSCC
with chronic mucocutaneous candidiasis and polyendocrinopathy-
candidiasis-ectodermal dystrophy has been previously described
[57,58]. These interesting observations warrant further explorations
to determine a correlation between farnesol production by C. albicans
and induction of apoptosis, because it may shed light on the mechan-
isms that C. albicans uses to colonize and potentially modify oral dys-
plastic and cancerous lesions.
The capability of farnesol to trigger apoptosis in mammalian can-
cer cells makes it a potential tool for studying tumor progression and
an attractive candidate as a therapeutic agent with antitumorigenic
properties. However, the mechanism by which farnesol preferentially
exerts its proapoptotic effect on cancer cells is not yet fully known.
What is known is that cancer cells are defective in some of their sig-
naling pathways secondary to genetic/epigenetic alterations of certain
genes, which could explain why tumor cells tend to be more sensitive
to farnesol. Hence, the precise pathway by which farnesol causes
apoptosis warrants further investigation. Future studies using our
proteomic analysis could potentially delineate how farnesol preferen-
tially targets transformed cells.
In conclusion, the combined findings from our study demonstrate
that farnesol induces an inhibition of cell growth and promotes
apoptosis in OSCCs through the induction of caspases, inhibition
of survivin, and down-regulation of various cellular metabolic mo-
dalities. In addition, we report for the first time that the ability of
a Candida-secreted substance to induce apoptosis is OSCCs through
the same pathways as synthetic farnesol. This study will enable
a better understanding of the molecular mechanisms underlying
farnesol-mediated antitumor effects at the protein level.
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